MicroRNA 29 targets nuclear factor-κB-repressing factor and claudin 1 to increase intestinal permeability

Gastroenterology

Volumn 148, Issue 1, 2015, Pages 158-169.e8

  Zhou, Qiqi ^a,b   Costinean, Stefan ^c   Croce, Carlo M ^c   Brasier, Alan R ^a   Merwat, Shehzad ^a   Larson, Scott A ^a   Basra, Sarpreet ^a   Verne, G Nicholas ^d  

^a University of Texas Medical Branch School of Medicine   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gene Regulation; Intestinal Barrier Function; Mouse Model; mRNA Processing

Indexed keywords

CLAUDIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA 29; CLDN1 PROTEIN, HUMAN; CLDN1 PROTEIN, MOUSE; MESSENGER RNA; MICRORNA; MIRN29 MICRORNA, HUMAN; MIRN29 MICRORNA, MOUSE; NKRF PROTEIN, HUMAN; NKRF PROTEIN, MOUSE; REPRESSOR PROTEIN; TRINITROBENZENESULFONIC ACID;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTRIC RESISTANCE; FEMALE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; INTESTINE MUCOSA PERMEABILITY; IRRITABLE COLON; KNOCKOUT MOUSE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CASE CONTROL STUDY; CELL LINE; CHEMICALLY INDUCED; COLITIS; COLON; DISEASE MODEL; DOWN REGULATION; GENE SILENCING; GENETIC PREDISPOSITION; GENETICS; INFLAMMATORY BOWEL DISEASE; METABOLISM; PATHOLOGY; PERMEABILITY; PHENOTYPE;

ANIMALS; CASE-CONTROL STUDIES; CELL LINE; CLAUDIN-1; COLITIS; COLON; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE KNOCKDOWN TECHNIQUES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; PERMEABILITY; PHENOTYPE; REPRESSOR PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRINITROBENZENESULFONIC ACID;

EID: 84922899761     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2014.09.037     Document Type: Article

References (40)

1. E.A. Mayer Irritable bowel syndrome N Engl J Med 358 2008 1692 1699
2. M. Simren, J. Axelsson, and H. Gillberg Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated factors Am J Gastroenterol 97 2002 389 396
3. M. Camilleri, K. Madsen, and R. Spiller Intestinal barrier function in health and gastrointestinal disease Neurogastroenterol Motil 24 2012 503 512
4. Q. Zhou, and G.N. Verne New insights into visceral hypersensitivity-clinical implications in IBS Nat Rev Gastroenterol Hepatol 8 2011 349 355
5. R.C. Spiller, D. Jenkins, and J.P. Thornley Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome Gut 47 2000 804 811
6. S.P. Dunlap, J. Hebden, and E. Campbell Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndrome Am J Gastroenterol 101 2007 1288 1294
7. Q. Zhou, B. Zhang, and G.N. Verne Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome Pain 146 2009 41 46
8. I. Bjarnason, A. MacPherson, and D. Hollander Intestinal permeability: an overview Gastroenterology 108 1995 1566 1581
9. A. Keshavarzian, E.W. Holmes, and M. Patel Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage Am J Gastroenterol 94 1999 200 207
10. Q. Zhou, W.W. Souba, and C. Croce MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome Gut 59 2010 775 784
11. Q. Zhou, D.D. Price, and R.M. Caudle Visceral and somatic hypersensitivity in a subset of rats following TNBS-induced colitis Pain 134 2008 9 15
12. S. Bradesi, I. Schwetz, and H.S. Ennes Repeated exposure to water avoidance stress in rats: a new model for sustained visceral hyperalgesia Am J Physiol Gastrointest Liver Physiol 289 2005 G42 G53
13. Q. Zhou, D.D. Price, and K.L. Dreher Localized colonic stem cell transplantation enhances tissue regeneration in murine colitis J Cell Mol Med 16 2012 1900 1915
14. S.Y. Park, J.H. Lee, and M. Ha miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42 Nat Struct Mol Biol 16 2009 23 29
15. J.J. Zhao, J. Lin, and T. Lwin MicroRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma Blood 115 2010 2630 2639
16. Y. Li, F. Wang, and J. Xu Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29 J Pathol 224 2011 484 495
17. Y. Sekiya, T. Ogawa, and K. Yoshizato Suppression of hepatic stellate cell activation by microRNA-29b Biochem Biophys Res Commun 412 2011 74 79
18. Z. Li, M.Q. Hassan, and M. Jafferji Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation J Biol Chem 284 2009 15676 15684
19. L. Meunier, B. Siddeek, and A. Vega Perinatal programming of adult rat germ cell death after exposure to xenoestrogens: role of microRNA miR-29 family in the down-regulation of DNA methyltransferases and Mcl-1 Endocrinology 153 2012 1936 1947
20. M. Fabbri, A. Garzon, and Z. Cimmino MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltranferases 3A and 3B PNAS 104 2007 15805 15810
21. I. Koturbash, F. Zemp, and B. Kolb Sex-specific radiation-induced microRNAome responses in the hippocampus, cerebellum and frontal cortex in a mouse model Mutat Res 722 2011 114 118
22. C.J. Creighton, A. Hernandez-Herrera, and A. Jacobsen Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma PLOS ONE 7 2012 e34546
23. T. Nguyen, C. Kuo, and M.B. Nicholl Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma Epigenetics 6 2011 388 394
24. N.J. Hand, A.M. Horner, and Z.R. Master MicroRNA profiling identifies miR-29 as a regulator of disease-associated pathways in experimental biliary atresia J Pediatr Gastroenterol Nutr 54 2012 186 192
25. E. Roggli, S. Gattesco, and D. Caille Changes in microRNA expression contribute to pancreatic β-cell dysfunction in prediabetic NOD mice Diabetes 61 2012 1742 1751
26. O. Kovalchuk, F.J. Zemp, and J.N. Filkowski microRNAome changes in bystander three-dimensional human tissue models suggest priming of apoptotic pathways Carcinogenesis 31 2010 1882 1888
27. Q. Ding, C.J. Chang, and X. Xie APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis J Clin Invest 121 2011 4526 4536
28. M. Kwiecinski, N. Elfimova, and A. Noetel Expression of platelet-derived growth factor-C and insulin-like growth factor I in hepatic stellate cells is inhibited by miR-29 Lab Invest 92 2012 978 987
29. F. Wu, M. Zikusoka, and A. Trindale MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha Gastroenterology 135 2008 1624 1635
30. J. Kapeller, L.A. Houghton, and H. Monnikes First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome Hum Mol Genet 17 2008 2967 2977
31. J. Haberle, B. Gorg, and F. Rutsch Congenital glutamine deficiency with glutamine synthetase mutations N Engl J Med 353 2005 1926 1933
32. N. Bertiaux-Vandaele, S.B. Youmba, and L. Belmonte The expression and cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype Am J Gastroenterol 106 2011 2165 2173
33. T. Inai, J. Kobayashi, and Y. Shibata Claudin-1 contributes to the epithelial barrier function in MDCK cells Eur J Cell Biol 78 1999 849 855
34. M. Nourbakhsh, and H. Hauser Constitutive silencing of IBF-beta promoter is mediated by NRF (NF-kappaB-repressing factor), a nuclear inhibitor of NF-kappaB EMBO J 18 1999 6415 6425
35. A.R. Brasier The nuclear factor-kappaB-interleukin-6 signaling pathway mediating vascular inflammation Cardiovasc Res 86 2010 211 218
36. R. Sen, and D. Baltimore Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism Cell 47 1986 921 928
37. T.Y. Ma, G.K. Iwamoto, and N.T. Hoa TNF-α-induced increase in intestinal epithelial tight junction permeability requires NF-κB activation Am J Physiol Gastrointest Liver Physiol 286 2004 G367 G376
38. G. Bamias, D. Corridoni, and T.T. Pizarro New insights into the dichotomous role of innate cytokines gut homeostasis and inflammation Cytokine 59 2012 451 459
39. P.M. Majewski, R.D. Thurston, and R. Ramalingam Cooperative role of NF-{kappa}B and poly(ADP-ribose) polymerase 1 (PARP-1) in the TNF-induced inhibition of PHEX expression in osteoblasts J Biol Chem 285 2010 34828 34838
40. Q. Zhou, and G.N. Verne miRNA-based therapies for the Irritable Bowel Syndrome Exp Opin Biol Ther 8 2011 991 995